Refereed journal article or data article (A1)

Admission Levels of Total Tau and β-Amyloid Isoforms 1–40 and 1–42 in Predicting the Outcome of Mild Traumatic Brain Injury

List of AuthorsIftakher Hossain, Mehrbod Mohammadian, Riikka S. K. Takala, Olli Tenovuo, Leire Azurmendi Gil, Janek Frantzén, Mark van Gils, Peter J. Hutchinson, Ari J. Katila, Henna-Riikka Maanpää, David K. Menon, Virginia F. Newcombe, Jussi Tallus, Kevin Hrusovsky, David H. Wilson, Jessica Gill, Kaj Blennow, Jean-Charles Sanchez, Henrik Zetterberg, Jussi P. Posti


Publication year2020

JournalFrontiers in Neurology

Journal name in sourceFRONTIERS IN NEUROLOGY

Journal acronymFRONT NEUROL

Volume number11

Number of pages9





Self-archived copy’s web address

Background: The purpose of this study was to investigate if admission levels of total tau (T-tau) and beta-amyloid isoforms 1-40 (A beta 40) and 1-42 (A beta 42) could predict clinical outcome in patients with mild traumatic brain injury (mTBI).
Methods: A total of 105 patients with mTBI [Glasgow Coma Scale (GCS) >= 13] recruited in Turku University Hospital, Turku, Finland were included in this study. Blood samples were drawn within 24 h of admission for analysis of plasma T-tau, A beta 40, and A beta 42. Patients were divided into computed tomography (CT)-positive and CT-negative groups. The outcome was assessed 6-12 months after the injury using the Extended Glasgow Outcome Scale (GOSE). Outcomes were defined as complete (GOSE 8) or incomplete (GOSE < 8) recovery. The Rivermead Post Concussion Symptoms Questionnaire (RPCSQ) was also used to assess mTBI-related symptoms. Predictive values of the biomarkers were analyzed independently, in panels and together with clinical parameters.
Results: The admission levels of plasma T-tau, A beta 40, and A beta 42 were not significantly different between patients with complete and incomplete recovery. The levels of T-tau, A beta 40, and A beta 42 could poorly predict complete recovery, with areas under the receiver operating characteristic curve 0.56, 0.52, and 0.54, respectively. For the whole cohort, there was a significant negative correlation between the levels of T-tau and ordinal GOSE score (Spearman rho = -0.231, p = 0.018). In a multivariate logistic regression model including age, GCS, duration of posttraumatic amnesia, Injury Severity Score (ISS), time from injury to sampling, and CT findings, none of the biomarkers could predict complete recovery independently or together with the other two biomarkers. Plasma levels of T-tau, A beta 40, and A beta 42 did not significantly differ between the outcome groups either within the CT-positive or CT-negative subgroups. Levels of A beta 40 and A beta 42 did not significantly correlate with outcome, but in the CT-positive subgroup, the levels of T-tau significantly correlated with ordinal GOSE score (Spearman rho = -0.288, p = 0.035). The levels of T-tau, A beta 40, and A beta 42 were not correlated with the RPCSQ scores.
Conclusions: The early levels of T-tau are correlated with the outcome in patients with mTBI, but none of the biomarkers either alone or in any combinations could predict complete recovery in patients with mTBI.

Downloadable publication

This is an electronic reprint of the original article.
This reprint may differ from the original in pagination and typographic detail. Please cite the original version.

Last updated on 2022-07-04 at 17:57